Related Experiment Video
Updated: Mar 6, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
KCC2 downregulation facilitates epileptic seizures.
Lulan Chen1, Li Wan1, Zheng Wu1
1Institutes of Brain Science, State Key Laboratory for Medical Neurobiology, Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, 200032, China.
Neuron-specific K+-Cl- cotransporter-2 (KCC2) downregulation precedes and contributes to seizure induction. Restoring KCC2 levels enhances seizure resistance, indicating KCC2 is a factor, not just a consequence, in epilepsy.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- GABA(A) receptor function relies on low intracellular chloride, maintained by KCC2 in adult neurons.
- KCC2 is known to be downregulated in epilepsy, but its temporal role is unclear.
Purpose of the Study:
- To investigate the temporal relationship between KCC2 downregulation and seizure induction.
- To determine if KCC2 downregulation influences seizure occurrence.
Main Methods:
- In vivo and in vitro models of epilepsy.
- Assessment of KCC2 expression levels via Western blot and immunofluorescence.
- Manipulation of KCC2 expression using plasmids (overexpression and shRNA) and lentivirus.
- Electrophysiological recordings (EEG) and behavioral seizure scoring (Racine Scale).
Main Results:
- KCC2 downregulation correlated with severe seizures (Racine Score III+) in vivo and preceded in vitro epileptiform activity.
- KCC2 overexpression increased resistance to convulsant-induced epileptiform activity.
- KCC2 suppression induced spontaneous epileptiform activity in vitro and seizures in vivo.
Conclusions:
- Altered KCC2 expression is a contributing factor to, rather than a consequence of, seizure occurrence.
- KCC2 plays a critical role in regulating neuronal excitability and seizure susceptibility.
More Related Videos
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: